English
  • Notice: Undefined variable: sectorLink in Drupal\five_paisa\Controller\StockDetailController->getSectorLink() (line 450 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  • Warning: array_column() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 33 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_multisort(): Argument #1 is expected to be an array or a sort flag in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 34 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_slice() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 36 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: Invalid argument supplied for foreach() in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 52 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Notice: Undefined index: open_price in Drupal\five_paisa\StockService::openPrevData() (line 3918 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: prev_close in Drupal\five_paisa\StockService::openPrevData() (line 3919 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: vol in Drupal\five_paisa\StockService::openPrevData() (line 3923 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_low in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3901 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_high in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3902 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_low in Drupal\five_paisa\StockService::dayLowData() (line 3884 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_high in Drupal\five_paisa\StockService::dayLowData() (line 3885 of modules/custom/five_paisa/src/StockService.php).
  1. Home
  2. Stocks
  3. Berldrg Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Beryl Drugs

    Small Cap
    ₹33.25
    +1 (3.1%)
    01 July, 2024 07:19 BSE: 524606 NSE: BERLDRGISIN: INE415H01017

    Start SIP in Beryl Drugs

    Start SIP

    Beryl Drugs Performance

    Day Range

    • Low 0
    • High 0
    ₹ 33

    52 Week Range

    • Low 0
    • High 0
    ₹ 33
    • Open Price0
    • Previous Close0
    • Volume

    Beryl Drugs Share Price

    • Over 1 Month +5.46%
    • Over 3 Month +13.37%
    • Over 6 Month +50.38%
    • Over 1 Year +102.74%

    Beryl Drugs Key Statistics

    Beryl Drugs Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 38886
    Operating Expenses Qtr Cr 37776
    Operating Profit Qtr Cr 01110
    Depreciation Qtr Cr 00000
    Interest Qtr Cr 00000
    Tax Qtr Cr 00000
    Net Profit Qtr Cr 00010
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 2727
    Operating Expenses Annual Cr 2425
    Operating Profit Annual in Cr 22
    Depreciation Cr 11
    Interest Annual Cr 00
    Tax Annual Cr 00
    Net Profit Annual Cr 11
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 12
    Cash from Investing Activity Annual Cr -1-1
    Cash from Financing Annual Activity Cr 0-1
    Net Cash Flow Annual Cr 0
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 98
    Fixed Assets Annual Cr 66
    Total Non Current Assets Annual Cr 77
    Total Current Assets Annual Cr 1010
    Total Assets Annual Cr 1718
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 1816
    ROE Annual % 99
    ROCE Annual % 1313
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 108
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Beryl Drugs

    Beryl Drugs Technicals

    EMA & SMA

    Current Price
    ₹33.25
    +1 (3.1%)
    pointer
    • Bullish Moving Average
    • ___
    • 6
    • Bearish Moving Average
    • ___
    • 10
    • 20 Day
    • ₹34.14
    • 50 Day
    • ₹34.29
    • 100 Day
    • ₹32.98
    • 200 Day
    • ₹29.33
    • 20 Day
    • ₹33.90
    • 50 Day
    • ₹34.79
    • 100 Day
    • ₹34.86
    • 200 Day
    • ₹28.74

    Beryl Drugs Resistance and Support

    PIVOT
    ₹32.
    Resistance
    First Resistance 33.29
    Second Resistance 34.60
    Third Resistance 35.89
    RSI 39.10
    MFI 73.10
    MACD Single Line -0.16
    MACD -0.50
    Support
    First Support 30.69
    Second Support 29.40
    Third Supoort 28.09

    Beryl Drugs Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,903 224,199 77.23
    Week 4,040 342,050 84.67
    1 Month 17,085 808,966 47.35
    6 Month 15,331 1,101,086 71.82

    Beryl Drugs Result Highlights

    Beryl Drugs Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Beryl Drugs Corporate Action

    Date Purpose Remarks
    2024-05-30 Audited Results
    2024-04-20 Others
    2024-02-12 Quarterly Results
    2023-11-08 Quarterly Results
    2023-08-25 A.G.M.

    Beryl Drugs MF Shareholding

    Name Amount(cr)

    Beryl Drugs FAQs

    What is Share Price of Beryl Drugs ?

    Beryl Drugs share price is ₹33 As on 01 July, 2024 | 07:05

    What is the Market Cap of Beryl Drugs ?

    The Market Cap of Beryl Drugs is ₹16.9 Cr As on 01 July, 2024 | 07:05

    What is the P/E ratio of Beryl Drugs ?

    The P/E ratio of Beryl Drugs is 21.9 As on 01 July, 2024 | 07:05

    What is the PB ratio of Beryl Drugs ?

    The PB ratio of Beryl Drugs is 1.9 As on 01 July, 2024 | 07:05

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.